Specific delivery of drugs to the brain
Details for Australian Patent Application No. 2004249172 (hide)
International Classifications
Event Publications
25 May 2006 Section 223 Application Allowed
Baxter International Inc. The time in which to enter the National Phase has been extended to 24 Mar 2006. Address for service in Australia - Peter Maxwell & Associates Level 6 60 Pitt Street Sydney NSW 2000
1 June 2006 PCT application entered the National Phase
PCT publication WO2004/112747 Priority application(s): WO2004/112747
9 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004249178-Substituted piperidine compounds and methods of their use
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser